First Trust Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.73M | Sell |
|
|||||
|
2025
Q1 | $19.2M | Buy |
|
|||||
|
2024
Q4 | $21.3M | Buy |
|
|||||
|
2024
Q3 | $14.5M | Buy |
|
|||||
|
2024
Q2 | $14.9M | Sell |
|
|||||
|
2024
Q1 | $26M | Sell |
|
|||||
|
2023
Q4 | $74.6M | Sell |
|
|||||
|
2023
Q3 | $66.9M | Sell |
|
|||||
|
2023
Q2 | $78.8M | Buy |
|
|||||
|
2023
Q1 | $62.1M | Buy |
|
|||||
|
2022
Q4 | $64.6M | Buy |
|
|||||
|
2022
Q3 | $52.6M | Buy |
|
|||||
|
2022
Q2 | $40.9M | Buy |
|
|||||
|
2022
Q1 | $53.8M | Sell |
|
|||||
|
2021
Q4 | $106M | Sell |
|
|||||
|
2021
Q3 | $125M | Sell |
|
|||||
|
2021
Q2 | $120M | Sell |
|
|||||
|
2021
Q1 | $105M | Sell |
|
|||||
|
2020
Q4 | $102M | Sell |
|
|||||
|
2020
Q3 | $122M | Sell |
|
|||||
|
2020
Q2 | $102M | Buy |
|
|||||
|
2020
Q1 | $73M | Buy |
|
|||||
|
2019
Q4 | $69.6M | Sell |
|
|||||
|
2019
Q3 | $76.7M | Sell |
|
|||||
|
2019
Q2 | $132M | Sell |
|
|||||
|
2019
Q1 | $160M | Sell |
|
|||||
|
2018
Q4 | $124M | Buy |
|
|||||
|
2018
Q3 | $116M | Buy |
|
|||||
|
2018
Q2 | $61.5M | Sell |
|
|||||
|
2018
Q1 | $62.8M | Buy |
|
|||||
|
2017
Q4 | $59.9M | Sell |
|
|||||
|
2017
Q3 | $59.9M | Buy |
|
|||||
|
2017
Q2 | $55.6M | Buy |
|
|||||
|
2017
Q1 | $35.8M | Sell |
|
|||||
|
2016
Q4 | $41.6M | Buy |
|
|||||
|
2016
Q3 | $43.4M | Sell |
|
|||||
|
2016
Q2 | $47.1M | Sell |
|
|||||
|
2016
Q1 | $65.5M | Sell |
|
|||||
|
2015
Q4 | $166M | Buy |
|
|||||
|
2015
Q3 | $127M | Sell |
|
|||||
|
2015
Q2 | $198M | Buy |
|
|||||
|
2015
Q1 | $169M | Buy |
|
|||||
|
2014
Q4 | $103M | Buy |
|
|||||
|
2014
Q3 | $22.9M | Sell |
|
|||||
|
2014
Q2 | $33.9M | Buy |
|
|||||
|
2014
Q1 | $30.6M | Buy |
|
|||||
|
2013
Q4 | $14.3M | Buy |
|
|||||
|
2013
Q3 | $10.4M | Buy |
|
|||||
|
2013
Q2 | $4.52M | Buy |
|